» Articles » PMID: 28747168

The Biobank for the Molecular Classification of Kidney Disease: Research Translation and Precision Medicine in Nephrology

Overview
Journal BMC Nephrol
Publisher Biomed Central
Specialty Nephrology
Date 2017 Jul 28
PMID 28747168
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Advances in technology and the ability to interrogate disease pathogenesis using systems biology approaches are exploding. As exemplified by the substantial progress in the personalized diagnosis and treatment of cancer, the application of systems biology to enable precision medicine in other disciplines such as Nephrology is well underway. Infrastructure that permits the integration of clinical data, patient biospecimens and advanced technologies is required for institutions to contribute to, and benefit from research in molecular disease classification and to devise specific and patient-oriented treatments.

Methods And Results: We describe the establishment of the Biobank for the Molecular Classification of Kidney Disease (BMCKD) at the University of Calgary, Alberta, Canada. The BMCKD consists of a fully equipped wet laboratory, an information technology infrastructure, and a formal operational, ethical and legal framework for banking human biospecimens and storing clinical data. The BMCKD first consolidated a large retrospective cohort of kidney biopsy specimens to create a population-based renal pathology database and tissue inventory of glomerular and other kidney diseases. The BMCKD will continue to prospectively bank all kidney biopsies performed in Southern Alberta. The BMCKD is equipped to perform molecular, clinical and epidemiologic studies in renal pathology. The BMCKD also developed formal biobanking procedures for human specimens such as blood, urine and nucleic acids collected for basic and clinical research studies or for advanced diagnostic technologies in clinical care. The BMCKD is guided by standard operating procedures, an ethics framework and legal agreements with stakeholders that include researchers, data custodians and patients. The design and structure of the BMCKD permits its inclusion in a wide variety of research and clinical activities.

Conclusion: The BMCKD is a core multidisciplinary facility that will bridge basic and clinical research and integrate precision medicine into renal pathology and nephrology.

Citing Articles

Norwegian kidney biopsy biobank (NorKiBB): organization, baseline characteristics, and generalizability of a low-cost national biobank.

Ovrehus M, Asbjorn K, Langlo R, Leh S, Eikrem O, Romundstad S BMC Nephrol. 2025; 26(1):76.

PMID: 39948520 PMC: 11827217. DOI: 10.1186/s12882-025-04007-4.


Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics.

Islamuddin M, Qin X Cell Death Discov. 2024; 10(1):229.

PMID: 38740765 PMC: 11091222. DOI: 10.1038/s41420-024-01996-3.


Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine.

Reznichenko A, Nair V, Eddy S, Fermin D, Tomilo M, Slidel T Kidney Int. 2024; 105(6):1263-1278.

PMID: 38286178 PMC: 11751912. DOI: 10.1016/j.kint.2024.01.012.


Unmet needs in clinical trials in CKD: questions we have not answered and answers we have not questioned.

Levin A, Borkum M Clin Kidney J. 2023; 16(3):437-441.

PMID: 36865013 PMC: 9972821. DOI: 10.1093/ckj/sfac226.


Detection and Typing of Renal Amyloidosis by Fluorescence Spectroscopy Using the Environmentally Sensitive Fluorophore K114.

Brandt P, Stepanchuk A, Andonegui G, Benediktsson H, Stys P, Muruve D Mol Imaging Biol. 2022; 25(1):221-227.

PMID: 35857157 DOI: 10.1007/s11307-022-01754-w.


References
1.
Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

2.
Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H . Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ. 2013; 185(9):E417-23. PMC: 3680588. DOI: 10.1503/cmaj.120833. View

3.
Javitt G . Take another little piece of my heart: regulating the research use of human biospecimens. J Law Med Ethics. 2013; 41(2):424-39. DOI: 10.1111/jlme.12053. View

4.
Navis G, Blankestijn P, Deegens J, De Fijter J, Homan van der Heide J, Rabelink T . The Biobank of Nephrological Diseases in the Netherlands cohort: the String of Pearls Initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands. Nephrol Dial Transplant. 2013; 29(6):1145-50. DOI: 10.1093/ndt/gft307. View

5.
Hewitt R . Biobanking: the foundation of personalized medicine. Curr Opin Oncol. 2010; 23(1):112-9. DOI: 10.1097/CCO.0b013e32834161b8. View